文献速递头颈部肿瘤放疗放疗物理与技术

儿童头颈放疗后唾液与牙齿并发症:PENTEC综合综述

Salivary and Dental Complications in Childhood Cancer Survivors Treated With Radiation Therapy to the Head and Neck: A PENTEC Comprehensive Review.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2021-05-29

该PENTEC综合综述系统评价儿童期接受头颈部放疗后唾液腺功能障碍与牙齿发育异常。唾液功能数据显示腮腺平均剂量35-40 Gy时急性和慢性≥2级口干风险分别约32%和13%-32%。建议腮腺平均剂量≤26 Gy,牙齿剂量尽量低,<4岁患儿尽量<20 Gy。

要点

  • 腮腺平均剂量35-40 Gy时急性≥2级口干风险约32%,慢性约13%-32%。
  • 推荐将腮腺平均剂量限制在≤26 Gy。
  • 牙齿发育异常最低毒性剂量未知,<4岁患儿尽量保持牙齿剂量<20 Gy。

核心结论

  • 采用成人唾液腺剂量约束是合理的策略,推荐腮腺平均剂量≤26 Gy。
  • 牙齿发育异常的最低毒性剂量未知,牙齿剂量应尽量低,尤其年幼患者。

研究设计与样本

  • PENTEC倡议下的系统综述,按PRISMA方法执行,纳入40篇文献进行定性合成、3篇进行定量合成。

主要发现

  • 腮腺平均剂量35-40 Gy与急性和慢性≥2级口干风险分别约32%和13%-32%相关,见于接受放化疗的患者。
  • 口干风险随腮腺剂量增加而升高,但低剂量暴露后的口干率未见报告。
  • 口腔放疗后牙齿发育异常常见,危险因素包括发育中牙齿受照剂量较高和放疗时年龄较小。

关键数值与推荐

  • 腮腺平均剂量35-40 Gy对应急性≥2级口干风险约32%、慢性≥2级口干风险13%-32%。
  • 推荐腮腺平均剂量≤26 Gy。
  • 对<4岁患者,尽量使牙齿剂量<20 Gy。

临床怎么用

  • 儿童头颈部放疗计划中可将腮腺平均剂量约束在≤26 Gy。
  • 对年幼患儿,尤其<4岁者,应尽量降低牙齿受照剂量,目标<20 Gy。

局限性

  • 牙齿发育异常的最低毒性剂量未知。
  • 低剂量暴露后的口干率尚未见报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Radiation therapy (RT) to the head and neck (H&N) region is critical in the management of various pediatric malignancies; however, it may result in late toxicity. This comprehensive review from the Pediatric Normal Tissue Effects in the Clinic (PENTEC) initiative focused on salivary dysfunction and dental abnormalities in survivors who received RT to the H&N region as children. MATERIALS & METHODS: This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) method. RESULTS: Of the 2,164 articles identified through a literature search, 40 were included in a qualitative synthesis and 3 were included in a quantitative synthesis. The dose-toxicity data regarding salivary function demonstrate that a mean parotid dose of 35 to 40 Gy is associated with a risk of acute and chronic grade ≥2 xerostomia of approximately 32% and 13% to 32%, respectively, in patients treated with chemo-radiation therapy. This risk increases with parotid dose; however, rates of xerostomia after lower dose exposure have not been reported. Dental developmental abnormalities are common after RT to the oral cavity. Risk factors include higher radiation dose to the developing teeth and younger age at RT. CONCLUSIONS: This PENTEC task force considers adoption of salivary gland dose constraints from the adult experience to be a reasonable strategy until more data specific to children become available; thus, we recommend limiting the parotid mean dose to ≤26 Gy. The minimum toxic dose for dental developmental abnormalities is unknown, suggesting that the dose to the teeth should be kept as low as possible particularly in younger patients, with special effort to keep doses <20 Gy in patients <4 years old.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Milgrom SA, van Luijk P, Pino R, et al. Salivary and Dental Complications in Childhood Cancer Survivors Treated With Radiation Therapy to the Head and Neck: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. 2021. PMID: 34074567. doi:10.1016/j.ijrobp.2021.04.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。